News Search Results
Nov 05, 2025, 10:31 ET ShipTime and Canadian Federation of Independent Business (CFIB) Expand Long-Standing Partnership to Deliver Game-Changing Benefits for Canadian Small Businesses
CFIB's work has been especially critical during times of uncertainty and disruption. From supporting small businesses through COVID-19, to standing up for them during postal strikes, border slowdowns, and trade challenges, CFIB has consistently been on the frontlines
More news about: ShipTime Canada Inc.
Nov 05, 2025, 08:44 ET IQ AIR: A Supplement Designed to Strengthen Lung Health
CNN Health also reports that as the fall chill sets in, the threat of respiratory viruses "like Covid-19, influenza, or RSV looms across the country." The number of lung-related respiratory illnesses that humans face each year during
More news about: LifeBridge
Nov 05, 2025, 07:55 ET Sempra Reports Third-Quarter 2025 Results
$(25) million impact from regulatory disallowances related to the recovery of coronavirus disease 2019 (COVID-19) costs at Sempra California $(121) million impact from foreign currency and inflation on our monetary positions in Mexico
More news about: Sempra
Nov 05, 2025, 05:18 ET Data Center Chip Market to Reach $45.3 Billion, Globally, by 2032 at 14.6% CAGR: Allied Market Research
Covid-19 Scenario The COVID-19 pandemic had a significant impact on the data center chip market. As more individuals switched to remote
More news about: Allied Market Research
Nov 05, 2025, 00:01 ET New Report: Lung Cancer Advancements Are Saving More Lives Than Ever, but Funding Cuts May Hinder Progress
Nationally, 20.7% of cases underwent surgery. Surgical treatment rates did not change over the previous five years, likely due to the impact of the COVID-19 pandemic on access to medical care. Lack of Treatment: There are multiple reasons
More news about: American Lung Association
Nov 04, 2025, 16:57 ET M-tron Industries, Inc. Reports Preliminary Third Quarter 2025 Results
1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as those pertaining to the uncertain financial impact of COVID-19 and the Company's financial condition, results of operations, business strategy and financial needs. All statements other than statements of current
More news about: Mtron
Nov 04, 2025, 15:07 ET AllOne Health Releases Largest-Ever Study of EAP Work/Life Services, Analyzing 59,000+ Real-World Cases
Consistent through disruption: Patterns of Work/Life use showed no meaningful differences by year or between the periods during and after the COVID-19 pandemic, underscoring a stable, ongoing demand for practical support. "Measuring EAP trends and impact
More news about: AllOne Health
Nov 04, 2025, 12:01 ET RedHill Announces $10.5 Million New York Supreme Court Judgment Win Now Final for Enforcement
for development for radiation and chemical exposure indications such as GI-Acute Radiation Syndrome (GI-ARS), a Phase 2/3 program for hospitalized COVID-19, and a Phase 2 study in prostate cancer in combination with darolutamide; (ii) RHB-204, a next-generation optimized formulation of RHB-104,
More news about: RedHill Biopharma Ltd.
Nov 04, 2025, 10:50 ET Point-of-Care Molecular Diagnostics Market Surges to USD 15.2 Billion by 2033, Propelled by 10.2% CAGR - Verified Market Reports®
prevalence of chronic and infectious diseases and a mature reimbursement framework. The region's emphasis on rapid testing and genomic surveillance post-COVID-19 has accelerated innovation and commercialization of compact, multiplexed platforms. Europe follows
More news about: Verified Market Reports
Nov 04, 2025, 09:30 ET Metsera Receives Amended Proposal from Novo Nordisk; Metsera Declares Novo Nordisk Amended Proposal "Superior"
processes, safety and/or other matters that could affect the availability or commercial potential of such products; uncertainties regarding the impact of COVID-19; and competitive developments. You should carefully consider the foregoing factors
More news about: Metsera, Inc.
Nov 04, 2025, 07:00 ET Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment
indicated for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 65 years of age and older, or 12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. IMPORTANT
More news about: Novavax, Inc.
Nov 04, 2025, 06:15 ET Party Supplies Market to Reach $28.7 Billion, Globally, by 2031 at 9.0% CAGR: Allied Market Research
Covid-19 scenario- The outbreak of the COVID-19 pandemic had a negative impact on the global party supplies market, owing to disruptions of the supply chain
More news about: Allied Market Research
Nov 04, 2025, 05:05 ET From Pandemic Innovation to Global Collaboration: Taiwan's TCM Shines at CPHI Frankfurt 2025
peer-reviewed studies, these formulas have demonstrated multi-target antiviral and anti-inflammatory effects, reducing ICU admissions and mortality in COVID-19 patients while protecting against lung injury and post-infection brain fog. Participating Taiwanese enterprises —Chuang
More news about: Taiwan Institute of Economic Research
Nov 04, 2025, 00:01 ET U.S. News & World Report Announces the 2026 Best Places to Retire
3 on the list. "Retirees are prioritizing quality of life over affordability for the first time since the beginning of the COVID-19 pandemic. This, coupled with an expanded number of places evaluated, allowed a number of midwestern cities to secure high positions in the rankings,"
More news about: U.S. News & World Report, L.P.
Nov 03, 2025, 11:02 ET Metsera Issues Statement in Response to Litigation
processes, safety and/or other matters that could affect the availability or commercial potential of such products; uncertainties regarding the impact of COVID-19; and competitive developments. You should carefully consider the foregoing factors and the other
More news about: Metsera, Inc.
Nov 03, 2025, 09:00 ET Tailored Brands Announces More than $16M Donated to U.S. Veterans Organizations
60,000 Hire Heroes USA clients have found success in their job search. All Hire Heroes services are being offered online or over the phone during the COVID-19 pandemic. This includes our volunteer services, which allow industry professionals to mentor and guide clients during their job search. Hire Heroes
More news about: Tailored Shared Services, LLC
Nov 03, 2025, 08:29 ET Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes
ViraxImmune™ T cell assay. The meeting provided constructive feedback on the Company's continued development of the assay for use in patients with post-acute COVID-19 infection. Virax is incorporating the Agency's recommendations into its ongoing clinical and analytical development programs to support progress toward
More news about: Virax BioLabs Group Limited
Nov 03, 2025, 08:12 ET New Novel Utilizes COVID-19 Lockdown to Expose Social Tensions and Personal Betrayals in a Quiet Canadian Neighborhood
multimedia:https://www.prnewswire.com/news-releases/new-novel-utilizes-covid-19-lockdown-to-expose-social-tensions-and-personal-betrayals-in-a-quiet-canadian-neighborhood-302600801.html
More news about: Archway Publishing
Nov 03, 2025, 08:00 ET Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine
introduce bias, the absence of adjustments for baseline differences between adherence groups, and the inclusion of study periods overlapping with the COVID-19 pandemic, during which restricted access to care and disruptions in the healthcare system may have influenced the findings.
More news about: Indivior PLC
Nov 03, 2025, 08:00 ET Servier Announces Positive Findings from Longer-Term Analysis of the Phase 3 INDIGO Trial Showing Continued Durable Treatment Effect of VORANIGO® (vorasidenib) Published in The Lancet Oncology
liver enzyme levels in the blood lack of energy, tiredness headache COVID-19 muscle aches or stiffness diarrhea nausea
More news about: Servier Pharmaceuticals
Nov 03, 2025, 07:00 ET VERSABANK ANNOUNCES LARGEST US RPP PARTNER TO DATE; SURPASSES US RPP TARGET WITH US$310 MILLION FUNDED IN FISCAL 2025
the impact of wars or conflicts including the crisis in Ukraine and the impact of the crisis on global supply chains; the impact of new variants of COVID-19 and the Bank's anticipation of and success in managing the risks implicated by the foregoing. For a detailed discussion of certain key factors that
More news about: VersaBank
Nov 03, 2025, 07:00 ET NAPCO Security Technologies, Inc. Reports Fiscal Q1 Results
trends, and anticipated product performance. These forward-looking statements include, but are not limited to, statements relating to the impact of COVID-19 pandemic; supply chain challenges and developments; the growth of recurring service revenues and annual run rate; the strength of our balance sheet;
More news about: NAPCO Security Technologies, Inc.
Nov 03, 2025, 07:00 ET Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress
competitors for products or product candidates in which Karyopharm is currently commercializing or developing; the direct or indirect impact of the COVID-19 pandemic or any future pandemic on Karyopharm's business, results of operations and financial condition; and Karyopharm's ability to obtain, maintain
More news about: Karyopharm Therapeutics Inc.
Nov 01, 2025, 08:00 ET Semaglutida entra para o "hall da fama" da revista Time como uma das melhores invenções dos últimos 25 anos
crônicas graves, acaba de ser incluída pela revista TIME na lista das invenções mais icônicas dos últimos 25 anos — ao lado da vacina de mRNA contra COVID-19, do iPhone e do YouTube. A molécula ganhou popularidade ao ter sua efetividade comprovada no tratamento da obesidade e sobrepeso.
More news about: NOVO NORDISK
Oct 31, 2025, 18:24 ET Metsera Issues Statement in Response to Litigation
processes, safety and/or other matters that could affect the availability or commercial potential of such products; uncertainties regarding the impact of COVID-19; and competitive developments. You should carefully consider the foregoing factors and the other
More news about: Metsera, Inc.